Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-17-005701
Filing Date
2017-05-22
Accepted
2017-05-22 16:40:12
Documents
47
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO QUARTERLY REPORT f10q1216a1_americanbrivision.htm 10-Q/A 284333
2 CERTIFICATION f10q1216a1ex31i_americanbri.htm EX-31.1 10728
3 CERTIFICATION f10q1216a1ex31ii_americanbri.htm EX-31.2 11098
4 CERTIFICATION f10q1216a1ex32i_americanbri.htm EX-32.1 4005
5 CERTIFICATION f10q1216a1ex32ii_americanbri.htm EX-32.2 3590
  Complete submission text file 0001213900-17-005701.txt   1836686

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20161231.xml EX-101.INS 251566
7 XBRL SCHEMA FILE mtoo-20161231.xsd EX-101.SCH 25954
8 XBRL CALCULATION FILE mtoo-20161231_cal.xml EX-101.CAL 23704
9 XBRL DEFINITION FILE mtoo-20161231_def.xml EX-101.DEF 58608
10 XBRL LABEL FILE mtoo-20161231_lab.xml EX-101.LAB 168558
11 XBRL PRESENTATION FILE mtoo-20161231_pre.xml EX-101.PRE 139519
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-91436 | Film No.: 17861429
SIC: 2834 Pharmaceutical Preparations